Discovery of cancer common and specific driver gene sets.

作者: Junhua Zhang , Shihua Zhang

DOI: 10.1093/NAR/GKX089

关键词:

摘要: Cancer is known as a disease mainly caused by gene alterations. Discovery of mutated driver pathways or sets becoming an important step to understand molecular mechanisms carcinogenesis. However, systematically investigating commonalities and specificities among multiple cancer types still great challenge, but this investigation will undoubtedly benefit deciphering cancers be helpful for personalized therapy precision medicine in treatment. In study, we propose two optimization models de novo discover common (ComMDP) specific one certain other (SpeMDP), respectively. We first apply ComMDP SpeMDP simulated data validate their efficiency. Then, further these methods 12 from The Genome Atlas (TCGA) obtain several biologically meaningful pathways. As examples, construct pathway model BRCA OV, infer complex carcinogenesis based on with eight types, investigate the liquid lymphoblastic acute myeloid leukemia (LAML) versus solid types. processes more candidate genes are also found.

参考文章(66)
Claire Cole, Sin Lau, Alison Backen, Andrew Clamp, Graham Rushton, Caroline Dive, Cassandra Hodgkinson, Rhona McVey, Henry Kitchener, Gordon C Jayson, Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer Cancer Biology & Therapy. ,vol. 10, pp. 495- 504 ,(2010) , 10.4161/CBT.10.5.12585
Giovanni Ciriello, Martin L Miller, Bülent Arman Aksoy, Yasin Senbabaoglu, Nikolaus Schultz, Chris Sander, Emerging landscape of oncogenic signatures across human cancers Nature Genetics. ,vol. 45, pp. 1127- 1133 ,(2013) , 10.1038/NG.2762
Elisabeth Remy, Sandra Rebouissou, Claudine Chaouiya, Andrei Zinovyev, François Radvanyi, Laurence Calzone, A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis Cancer Research. ,vol. 75, pp. 4042- 4052 ,(2015) , 10.1158/0008-5472.CAN-15-0602
Qinghua Cui, Yun Ma, Maria Jaramillo, Hamza Bari, Arif Awan, Song Yang, Simo Zhang, Lixue Liu, Meng Lu, Maureen O'Connor‐McCourt, Enrico O Purisima, Edwin Wang, A map of human cancer signaling Molecular Systems Biology. ,vol. 3, pp. 152- 152 ,(2007) , 10.1038/MSB4100200
Junfei Zhao, Shihua Zhang, Ling-Yun Wu, Xiang-Sun Zhang, Efficient methods for identifying mutated driver pathways in cancer Bioinformatics. ,vol. 28, pp. 2940- 2947 ,(2012) , 10.1093/BIOINFORMATICS/BTS564
Douglas Hanahan, Robert A. Weinberg, Hallmarks of cancer: the next generation. Cell. ,vol. 144, pp. 646- 674 ,(2011) , 10.1016/J.CELL.2011.02.013
Shihua Zhang, Chun-Chi Liu, Wenyuan Li, Hui Shen, Peter W. Laird, Xianghong Jasmine Zhou, Discovery of multi-dimensional modules by integrative analysis of cancer genomic data Nucleic Acids Research. ,vol. 40, pp. 9379- 9391 ,(2012) , 10.1093/NAR/GKS725
F. Vandin, E. Upfal, B. J. Raphael, De novo discovery of mutated driver pathways in cancer Genome Research. ,vol. 22, pp. 375- 385 ,(2012) , 10.1101/GR.120477.111
, International network of cancer genome projects web science. ,vol. 464, pp. 993- 998 ,(2010) , 10.1038/NATURE08987
R. Beroukhim, G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, I. Vivanco, J. C. Lee, J. H. Huang, S. Alexander, J. Du, T. Kau, R. K. Thomas, K. Shah, H. Soto, S. Perner, J. Prensner, R. M. Debiasi, F. Demichelis, C. Hatton, M. A. Rubin, L. A. Garraway, S. F. Nelson, L. Liau, P. S. Mischel, T. F. Cloughesy, M. Meyerson, T. A. Golub, E. S. Lander, I. K. Mellinghoff, W. R. Sellers, Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 20007- 20012 ,(2007) , 10.1073/PNAS.0710052104